16 results match your criteria: "University College London and University College London Hospital[Affiliation]"
Eur Urol
October 2024
Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Lancet Oncol
July 2024
Diagnostic Image Analysis Group, Radboud University Medical Center, Nijmegen, Netherlands; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Tronheim, Norway.
Background: Artificial intelligence (AI) systems can potentially aid the diagnostic pathway of prostate cancer by alleviating the increasing workload, preventing overdiagnosis, and reducing the dependence on experienced radiologists. We aimed to investigate the performance of AI systems at detecting clinically significant prostate cancer on MRI in comparison with radiologists using the Prostate Imaging-Reporting and Data System version 2.1 (PI-RADS 2.
View Article and Find Full Text PDFJ Nucl Med
April 2024
Institute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom.
The use of [F]FDG PET/CT as a biomarker in diffuse lung diseases is increasingly recognized. We investigated the correlation between [F]FDG uptake with histologic markers on lung biopsy of patients with fibrotic interstitial lung disease (fILD). We recruited 18 patients with fILD awaiting lung biopsy for [F]FDG PET/CT.
View Article and Find Full Text PDFEur Urol
April 2023
Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Eur Urol
June 2022
Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Background: Recurrent prostate cancer after radiotherapy occurs in one in five patients. The efficacy of prostate magnetic resonance imaging (MRI) in recurrent cancer has not been established. Furthermore, high-quality data on new minimally invasive salvage focal ablative treatments are needed.
View Article and Find Full Text PDFObjective: A subset of patients with seropositive rheumatoid arthritis (RA) do not mount a C-reactive protein (CRP) response during flares. We hypothesize that these patients are more likely to experience poor clinical care and less likely to respond to traditional therapy. This study questioned whether this presentation was associated with worse disease outcome and distinct immunological features.
View Article and Find Full Text PDFEur Urol Oncol
May 2019
Erasmus Medical Center, Rotterdam, The Netherlands.
Within the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) initiative, 25 centers across the globe collaborate to standardize active surveillance (AS) protocols for men with low-risk prostate cancer (PCa). A centralized PCa AS database, comprising data of more than 15000 patients worldwide, was created. Comparability of the histopathology between the different cohorts was assessed by a centralized pathology review of 445 biopsies from 15 GAP3 centers.
View Article and Find Full Text PDFBMJ Open
October 2017
Division of Surgery and Interventional Science, University College London, London, UK.
Introduction: The classical pathway for the diagnosis of prostate cancer is transrectal ultrasound-guided (TRUS) biopsy of the prostate initiated on the basis of a raised prostate-specific antigen (PSA). An alternative pathway is to perform multi-parametricMRI (MPMRI) to localise cancer and to use this information to influence the decision for, and conduct of, a subsequent biopsy, known as an MPMRI-targeted biopsy. An MPMRI pathway has been shown to detect a similar or greater amount of clinically significant cancer as TRUS biopsy but has several advantages, including the potential to biopsy fewer men with fewer cores.
View Article and Find Full Text PDFTransl Androl Urol
June 2017
Department of Urology, CHU Lille, University of Lille, F-59000 Lille, France.
The role of magnetic resonance imaging (MRI) prior to biopsy in the diagnosis of prostate cancer in biopsy-naïve patients has been strengthened by recent developments such as the PIRADS V2 criteria, which cover acquisition, interpretation, and reporting for clinical practice and data collection for research. Important questions on the role of prostate MRI remain: can MRI be used as a triage test before first biopsy series? Can it be used to avoid the use of systematic biopsies (SB) and instead use only targeted biopsies (TB) to MRI-suspicious lesions? Studies to evaluate image guided TB compared to SB have started to accumulate. Objectives of these studies should be to reduce the detection of clinically insignificant disease, to maximize the detection of clinically significant cancer (CSC), to better assess disease size, grade and location.
View Article and Find Full Text PDFGastroenterol Nurs
January 2015
Indira Nathan, PhD, BSc (Hons), SRD, is Research Associate, Centre for Gastroenterology and Nutrition, University College London, London, England. Christine Norton, PhD, MA, RN, is Florence Nightingale Professor of Clinical Nursing Research, King's College London, Florence Nightingale School of Nursing and Midwifery, London, England. Wladyslawa Czuber-Dochan, MSc, PGPD, RN, RNT, is PhD Research Fellow, King's College London, Florence Nightingale School of Nursing and Midwifery, London, England. Alastair Forbes, MD, FRCP, FHEA, is Professor of Gastroenterology and Clinical Nutrition, University College London and University College London Hospital, Department of Gastroenterology, London, England.
There is increasing evidence that exercise may improve symptoms in individuals with inflammatory bowel disease (IBD). This study aims to explore issues that clinicians may need to consider when giving advice on exercise to such individuals. Limited existing evidence suggests that low to moderate physical activity may improve symptoms without any adverse effects in individuals with IBD.
View Article and Find Full Text PDFJ Endovasc Ther
February 2011
Multidisciplinary Endovascular Team, University College London and University College London Hospital, London, UK.
Purpose: To review the early outcome following endovascular repair of pararenal aortic aneurysm using fenestrated stent-grafts and to determine if the number of fenestrations required is predicative of outcome.
Methods: A retrospective analysis was conducted of 20 consecutive patients (18 men; mean age of 75 ± 7 years) treated with stent-grafts containing either ≤ 2 fenestrations (n = 10, group 1) or 3 fenestrations (n = 10, group 2). Target vessels also included those accommodated by a scallop (renal artery or superior mesenteric artery in group 1 and the celiac artery in group 2).
J Endovasc Ther
August 2010
Multidisciplinary Endovascular Team, University College London and University College London Hospital, London, UK.
Purpose: To describe a novel technique for target vessel catheterization in patients with juxtarenal abdominal aortic aneurysms requiring treatment with fenestrated stent-grafts (FSG).
Methods: The standard FSG design was modified, substituting a thin-wall tube for the solid central obturator that serves as both an attachment point for the distal end of the graft as well as a top cap retriever. Through this tube, two 0.
Acta Chir Belg
May 2010
Multidisciplinary Endovascular Team, University College London and University College London Hospital, London NW1 2BU, England.
Stent graft placement for aneurysmal disease of the aortic arch and proximal descending aorta is limited by the need to preserve flow to the supra-aortic trunks. Whilst extra-anatomical bypass and procedures combining open and endovascular arch repair are currently used in this setting, less invasive totally endovascular solutions have been described. These include in-situ fenestration of a thoracic stent graft using a retrograde approach from the target vessel to the lumen of the main device, to which it is connected by a smaller covered stent.
View Article and Find Full Text PDFEur J Vasc Endovasc Surg
April 2010
Multidisciplinary Endovascular Team, University College London and University College London Hospital, 235 Euston Road, London, England, UK.
Objective: A prototype ready-to-fenestrate stent graft (RFSG) was designed with a fixed scallop, and eight potential fenestrations allowing for variation in the position of each renal artery (RA) relative to the superior mesenteric artery (SMA). We aimed to determine the proportion of juxtarenal aneurysms treatable using this potentially 'off-the-shelf' device.
Methods: A total of 439 consecutive orders for custom-made devices were analysed, and positions for potential fenestrations in the RFSG were determined, based on the most frequent anatomical target vessel variations: a fixed SMA scallop 12 mm deep at 12:00, RA fenestrations at 9:15, 10:15 (target within the range 8:45-10:45), 2:15 and 3:15 (target within the range 1:45-3:45), each either 19 or 28 mm from the graft edge (GE); (within the range 15-32 mm), and 6 x 8 mm in diameter.
Atherosclerosis
July 2010
Institute of Nuclear Medicine, University College London and University College London Hospital, London, UK.
Purpose: Increased uptake of 18F-fluorodeoxyglucose (18F-FDG) in atherosclerotic plaque on Positron Emission Tomography (PET), predicts vulnerability. Recent studies have shown that the PET signal is reproducible over a 2-week period and as a result drug trials are underway. However, the natural history of these lesions is unknown.
View Article and Find Full Text PDFJ Vasc Surg
August 2010
University College London and University College London Hospital, 235 Euston Road, London NW1 2BU, England.
In situ fenestration of aortic stent grafts has the potential to allow for continued perfusion of supra-aortic trunks, without the need for extra-anatomic bypass, and without the need for custom-made devices. Angulation of the target vessel relative to the arch is an obstacle to success with this technique. In this report, we describe a case of successful in situ fenestration of the left subclavian artery (LSA) in a patient with an aortic arch aneurysm, treated with an endovascular stent graft.
View Article and Find Full Text PDF